Ionis Pharmaceuticals (IONS) PT Raised to $69 at Citi
Tweet
Share
E-mailGet Alerts IONS Hot Sheet
Price: $61.33 +2.42%
Rating Summary:
17 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Rating Summary:
17 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Join SI Premium – FREE
Citi analyst David Lebowitz raised the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $69.00 (from $65.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi reiterates Buy rating on Baidu with $166 price target, Opens 30 Day Upside Catalyst Watch
- JPMorgan reduced lending to Jane Street over bond market competition - FT
- EagleOne Metals raises private placement ceiling to $225,199
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Citi, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
